The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF)

Transfusion and Apheresis Science

Volumn 40, Issue 1, 2009, Pages 41-47

  Nakamura, Masataka ^a   Oda, Shigeto ^a   Sadahiro, Tomohoto ^a   Hirayama, Yoh ^a   Tateishi, Yoshihisa ^a   Abe, Ryuzo ^a   Hirasawa, Hiroyuki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA CHDF); Cytokine modulator; Hypercytokinemia; Multiple organ failure; Tumor lysis syndrome (TLS)

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; INTERLEUKIN 10; INTERLEUKIN 6; POLY(METHYL METHACRYLATE); PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CASE REPORT; CONTINUOUS HEMODIAFILTRATION; CREATININE BLOOD LEVEL; FEMALE; FILTER; HEMATOLOGIC DISEASE; HUMAN; HYPERCYTOKINEMIA; HYPERKALEMIA; HYPERURICEMIA; INTENSIVE CARE UNIT; MALE; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SURVIVAL; T CELL LYMPHOMA; TUMOR LYSIS SYNDROME; UNIVERSITY HOSPITAL; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; CYTOKINES; FEMALE; HEMATOLOGIC NEOPLASMS; HEMODIAFILTRATION; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POLYMETHYL METHACRYLATE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TUMOR LYSIS SYNDROME;

EID: 59649097568     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2008.11.004     Document Type: Article

References (24)

1. Jones D.P., Mahmoud H., and Chesney R.W. Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 9 (1995) 206-208
2. Davidoson M.B., Thakkar S., Hix J.K., Bhandarker N.D., Wong A., and Schreiber M.J. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 116 (2004) 546-554
3. Coiffier B., Altman A., Pui C.H., Younes A., and Cairo M.S. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26 (2008) 2767-2778
4. Annane D., Bellissant E., and Cavaillon J.M. Septic shock. Lancet 365 (2005) 63-78
5. Lenz A., Franklin G.A., and Cheadle W.G. Systemic inflammation after trauma. Injury 38 (2007) 1336-1345
6. Schonbohn H., Schuler M., Kolbe K., Peschel C., Huber C., Bemb W., et al. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia. Ann Hematol 71 (1995) 161-168
7. Hsu H.C., Lee Y.M., Tsai W.H., Jiang M.L., Ho C.H., Ho C.K., et al. Circulating levels of thrombopoietic inflammatory cytokines in patients with acute myeloblastic leukemia and myeloblastic syndrome. Oncology 63 (2002) 64-69
8. Tsuchijima J., Imajo K., Yoshino T., Nanba N., Toyota A., Yoshida C., et al. High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases. Ann Hematol 81 (2002) 588-592
9. Hall P.D., Benko H., Hogan K.R., and Stuart R.K. The influence of serum tumor necrosis factor-alpha and interleukin-6 concentrations on nonhematologic toxicity and hematologic recovery in patients with acute myelogeneous leukemia. Exp Hematol 23 (1995) 1256-1260
10. Li L., Pan J., and Yu Y. Development of sorbent therapy for multiple organ dysfunction syndrome (MODS). Biomed Mater 2 (2007) R12-16
11. Haase M., Bellomo R., Morgera S., Baldwin I., and Boyce N. High cut-off point membranes in septic acute renal failure: a systematic review. Int J Artif Organs 30 (2007) 1031-1041
12. Honoré P.M., Joannes-Boyau O., and Gressens B. Blood and plasma treatments: the rationale of high-volume hemofiltration. Contrib Nephrol 156 (2007) 387-395
13. Hirasawa H., Oda S., and Matsuda K. Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock. Contrib Nephrol 156 (2007) 365-370
14. Ronco C., Inguaggiato P., Bordoni V., De Cal M., Bonello M., Andrikos E., et al. Rasburicase therapy in acute hyperuricemia and renal dysfunction. Contrib Nephrol 147 (2005) 115-123
15. Marenco J.P., Nervi A., and White A.C. ARDS associated with tumor lysis syndrome in a patient with non-Hodgkin's lymphoma. Chest 113 (1998) 550-552
16. Lacatelli F., and Rossi F. Incidence and pathogenesis of tumor lysis syndorome. Contrib Nephrol 147 (2005) 61-68
17. Hoffmann J.N., and Faist E. Removal of mediators by continuous hemofiltration in septic patients. World J Surg 25 (2001) 651-659
18. Ghani R.A., Zainudin S., Ctkong N., Rahman A.F., Wafa S.R., Mohamad M., et al. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration. Nephrology 11 (2006) 386-393
19. Uchino S., Bellomo R., Goldsmith D., Davenport P., Cole L., Baldwin I., et al. Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med 28 (2002) 651-655
20. Matsuda K., Hirasawa H., Oda S., Shiga H., and Nakanishi K. Current topics on cytokine removal technologies. Ther Apher 5 (2001) 306-314
21. Oda S., Hirasawa H., Shiga H., Nakanishi K., Matsuda K., and Nakamura M. Continuous hemofiltration/hemodiafiltration in critical care. Ther Apher 6 (2002) 193-198
22. Nakada T.A., Oda S., Matsuda K., Sadahiro T., Nakamura M., Abe R., et al. Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock. Mol Med 14 (2008) 257-263
23. Oda S., Hirasawa H., Shiga H., Matsuda K., Nakamura M., Watanabe E., et al. Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter. Ther Apher Dial 9 (2005) 355-361
24. Nakanishi K., Hirasawa H., Sugai T., Oda S., Shiga H., Kitamura N., et al. Efficacy of continuous hemodiafiltration for patients with congestive heart failure. Blood Purif 20 (2002) 342-348